Sandu Pharmaceuticals Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Sandu Pharmaceuticals has a total shareholder equity of ₹405.9M and total debt of ₹633.0K, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are ₹524.1M and ₹118.2M respectively. Sandu Pharmaceuticals's EBIT is ₹17.3M making its interest coverage ratio 28.4. It has cash and short-term investments of ₹12.1M.
Belangrijke informatie
0.2%
Verhouding schuld/eigen vermogen
₹633.00k
Schuld
| Rente dekkingsratio | 28.4x |
| Contant | ₹12.06m |
| Aandelen | ₹405.93m |
| Totaal verplichtingen | ₹118.22m |
| Totaal activa | ₹524.15m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: 524703's short term assets (₹223.0M) exceed its short term liabilities (₹106.4M).
Langlopende schulden: 524703's short term assets (₹223.0M) exceed its long term liabilities (₹11.8M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 524703 has more cash than its total debt.
Schuld verminderen: 524703's debt to equity ratio has reduced from 21.2% to 0.2% over the past 5 years.
Schuldendekking: 524703's debt is well covered by operating cash flow (1200.5%).
Rentedekking: 524703's interest payments on its debt are well covered by EBIT (28.4x coverage).